| Full Name | Marc Zekowski |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 21 Waterville Rd, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326143736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 001899 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marc Zekowski, PHD 18 Forest Hills Dr, West Hartford, CT 06117 Ph: (860) 233-5313 | Marc Zekowski, PHD 21 Waterville Rd, Avon, CT 06001 Ph: (860) 674-2691 |
News Archive
Trubion Pharmaceuticals, Inc. today announced that its collaboration partner, Pfizer, has initiated a Phase 2 clinical trial of SBI-087 (PF-05230895) for the treatment of rheumatoid arthritis (RA). SBI-087 is a next-generation, humanized Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic directed against the CD20 antigen. SBI-087 is also being evaluated in Phase 1 clinical trials for RA and systemic lupus erythematosus (SLE).
Awareness, treatment and control of high blood pressure have increased significantly in England, according to a nationally representative health survey reported in Hypertension: Journal of the American Heart Association.
Centocor, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted its filing of a supplemental Biologics License Application (sBLA) for REMICADE® (infliximab) as first-line therapy, in combination with methotrexate, for the treatment of early rheumatoid arthritis (RA) patients with moderately-to-severely active disease. REMICADE®, in combination with methotrexate, is currently indicated in the U.S. for reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately-to-severely active RA who have had an inadequate response to methotrexate alone.
A wild carnivorous marsupial which only exists on the Australian island state of Tasmania has been found to have high levels of flame retardant chemicals.
From a quantitative standpoint, mineral oil is probably the largest contaminant of our body. That this contaminant can be tolerated without health concerns in humans has not been proven convincingly.
› Verified 1 days ago
Elizabeth S Thayer, PHD CLINICAL PSYCHOL Psychologist Medicare: Not Enrolled in Medicare Practice Location: 40 Dale Road, Suite 201, Avon, CT 06001 Phone: 860-676-9350 Fax: 860-678-7178 | |
Dorica Nevin, PSYD. Psychologist Medicare: May Accept Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0181 Fax: 860-284-6804 | |
Judith Davidson, PHD Psychologist Medicare: May Accept Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691 Fax: 860-677-6443 | |
Wendy F Habelow, PHD CLINICAL PSYCHOL Psychologist Medicare: Not Enrolled in Medicare Practice Location: 40 Dale Road, Suite 201, Avon, CT 06001 Phone: 860-676-9350 Fax: 860-678-7178 | |
Dr. Samuel Moy, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7 Rexinger Ln, Avon, CT 06001 Phone: 860-704-6188 | |
Hsiao-ching Chu, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1 Darling Dr Ste 16, Avon, CT 06001 Phone: 860-798-4148 | |
Ted Scott Sewitch, PHD CLINICAL PSYCHOL Psychologist Medicare: Not Enrolled in Medicare Practice Location: 40 Dale Road, Suite 201, Avon, CT 06001 Phone: 860-676-9350 Fax: 860-678-7178 |